European Leukemia Trial Registry
Trial: AMLSG 18-12

More Details
Short Title AMLSG 18-12
Trialgroup AMLSG Ulm
Type of Trial NIS, multicentric, single-group, prospective, open-label
Disease Acute myeloid leukemia(AML) AML all subtypes without FAB M3
Age >= 18 years
Status No longer recruiting
Start of Recruitment 01.02.2013
Leader Greiner, Prof., Jochen
Contactperson

Study Centre
Rudolph, Christiane
Tel: +49 (0)731 500 45903
Fax: +49 (0)731 500 45905
Email: christiane.rudolph@uniklinik-ulm.de

Centre of Trial Universitätsklinikum Ulm
Shortprotocol Shortprotocol
Diagnostics

Cytogenetics
Labor für Zytogenetische und Molekulargenetische Diagnostik, Klinik für Innere Med. III, Universitätsklinikum Ulm

created 13.02.2013 Johannes Kraus
changed 09.04.2018 Martina Wolkenfeld
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org